NEXGEL, INC. Business Acquisition, Pro Forma Revenue
NEXGEL, INC. (NXGL) reported Business Acquisition, Pro Forma Revenue of $1.55 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-21.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2022-03-21
- NEXGEL, INC. business acquisition, pro forma revenue for the quarter ending 2021-12-31 was $533.00, a 427.72% increase year-over-year.
- NEXGEL, INC. business acquisition, pro forma revenue for the quarter ending 2021-09-30 was $335.00.
- NEXGEL, INC. business acquisition, pro forma revenue for the quarter ending 2021-06-30 was $416.00, a 99.88% decline year-over-year.
- NEXGEL, INC. business acquisition, pro forma revenue for the quarter ending 2021-03-31 was $267.00, a 23.28% decline year-over-year.
- NEXGEL, INC. business acquisition, pro forma revenue for fiscal 2021 was $1.55K, a 124.46% increase from fiscal 2020.
- NEXGEL, INC. business acquisition, pro forma revenue for fiscal 2020 was $691.00, a 9.08% decline from fiscal 2019.
- NEXGEL, INC. business acquisition, pro forma revenue for fiscal 2019 was $760.00.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $533.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $868.00 derived: sum of 2 quarters · filed 2022-03-21 | $1.28K derived: sum of 3 quarters · filed 2022-03-21 | $1.55K 10-K · filed 2022-03-21 | |
| 2021-09-30 | $335.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $751.00 derived: sum of 2 quarters · filed 2021-11-10 | $1.02K 10-Q · filed 2021-11-10 | $1.12K derived: sum of 4 quarters · filed 2022-03-21 | |
| 2021-06-30 | $416.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $683.00 10-Q · filed 2021-08-16 | $784.00 derived: sum of 3 quarters · filed 2022-03-21 | -$346.63K derived: sum of 4 quarters · filed 2022-03-21 | |
| 2021-03-31 | $267.00 10-Q · filed 2021-05-17 | $368.00 derived: sum of 2 quarters · filed 2022-03-21 | -$347.04K derived: sum of 3 quarters · filed 2022-03-21 | $610.00 derived: sum of 4 quarters · filed 2022-03-21 | |
| 2020-12-31 | $101.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$347.31K derived: sum of 2 quarters · filed 2022-03-21 | $343.00 derived: sum of 3 quarters · filed 2022-03-21 | $691.00 10-K · filed 2022-03-21 | |
| 2020-09-30 | -$347.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $242.00 derived: sum of 2 quarters · filed 2021-11-10 | $590.00 10-Q · filed 2021-11-10 | $781.00 derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $347.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $348.00K 10-Q · filed 2020-08-14 | $348.19K derived: sum of 3 quarters · filed 2021-08-16 | $81.76K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $348.00 10-Q · filed 2021-08-16 | $254.00 10-Q · filed 2021-05-17 | $539.00 derived: sum of 2 quarters · filed 2021-08-16 | -$265.89K derived: sum of 3 quarters · filed 2021-08-16 | |
| 2019-12-31 | $191.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$266.24K derived: sum of 2 quarters · filed 2021-03-31 | $760.00 10-K · filed 2021-03-31 | ||
| 2019-09-30 | -$266.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $569.00 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $267.00K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |